CHUGAI PHARMACEUTICAL CO., LTD.
4519・Prime Market・Pharmaceuticals
Governance
A company with a Board of Corporate Auditors. The Board of Directors consists of 9 members (3 executive directors and 6 non-executive directors, of whom 3 are independent outside directors), with at least one-third of directors elected as independent outside directors. Voluntary advisory bodies, including a Nomination Committee, Compensation Committee, and Special Committee (for managing conflicts of interest with parent company Roche), have been established to ensure transparency and fairness in management.
Risk Management
The company has established a "Risk Appetite Statement" to foster a sound risk culture. Based on the "Risk Management Policy" and "Risk Management Regulations," a Risk Management Committee has been set up as a subordinate body to the Management Committee, and risks are classified and managed as strategic risks and operational risks. Departmental Risk and Compliance Committees are established in each department and subsidiary, and a system is in place to set up an Emergency Response Headquarters headed by the Representative Director in the event of a serious emergency. For climate change risk, scenario analysis under 1.5°C and 4°C scenarios is conducted based on the TCFD framework, and priorities are determined using residual risk scores.
Shareholder Returns
For FY2026 (ending March 2026)... wait, this is a calendar-year company; continuing policy targeting Core payout ratio of approximately 44.7%. Annual dividend forecast is ¥132 (interim ¥66, year-end ¥66), an increase of ¥10 from the ordinary dividend of ¥122 in the prior period (excluding the ¥150 special dividend commemorating the 100th anniversary of founding). 1Q progress rate is 24.4%, tracking steadily against the full-year forecast.
Dividend Policy
Stable dividends are paid with a target payout ratio averaging around 45% relative to Core EPS. The basic policy is to pay dividends twice a year, comprising an interim dividend and a year-end dividend. The annual dividend forecast for the fiscal year ending December 2026 is ¥132 per share (interim ¥66, year-end ¥66), with a Core payout ratio of 44.7%. In the prior period (fiscal year ended December 2025), an annual dividend of ¥272 was paid, comprising an ordinary dividend of ¥122 plus a ¥150 special dividend commemorating the company's 100th anniversary of founding. As of the end of the first quarter of the fiscal year ending December 2026, there has been no revision to the earnings forecast.
ESG
サステナビリティを事業活動の中心に据え、2024年にダブルマテリアリティ評価に基づき16項目の重要課題を特定。気候変動対策では2025年に全拠点の調達電力100%再生可能エネルギー化を達成し、Scope1+2 CO₂排出量を基準年比55.8%削減（2025年目標40%削減を超過達成）。TCFDおよびTNFD（2025年6月Adopter登録）フレームワークに沿って情報開示。人的資本では2025年1月に新人事制度（ジョブポスティング制度等）を導入し、女性マネジャー比率は2022年15.9%から2025年19.2%に向上。男性育児休業取得率93.4%・平均取得日数37.7日。ESGの達成状況を業務執行取締役の賞与指標に組み込み、役員報酬と連動させている。
Last updated: March 25, 2026